Help us fund an affordable and accessible COVID-19 test with local, national, and global impact.
The faster we can diagnose everybody affected by the disease, the faster we can contain the spread and help those in need.
Pittsburgh-based Basic Health International is working with a biomedical engineering company to help validate a new COVID-19 test. This test will be faster and less costly than the current CDC test, making it more feasible for use in low-resource settings- and helping the most vulnerable among us here at home and throughout the world.
The test will not require the use of DNA/RNA extraction reagents that are currently the limiting factor in making testing more widely available in the United States. BHI has experience screening large populations, and the development of this new test will allow us and other health care professionals to bring testing to vulnerable groups, where the spread of the virus can be devastating.
This new COVID-19 platform will be ideally suited for use in the countries where we currently work and in communities throughout the United States because it is inexpensive, requires little equipment, and results will be available in less than an hour.
Help us stop this crisis! Please contribute- no amount is too small or too large.
Who we are:
Led and founded by Dr. Miriam Cremer, Basic Health International is a globally recognized as a leader in the secondary prevention of cervical cancer. BHI provides clinical training, research, and public policy guidance in the field of cervical cancer screening and treatment, particularly for women in low-resource settings. BHI's mission is to live in a world where no woman dies of cervical cancer. The non-profit organization, comprised of top tier medical and research professionals, works in underserved countries and communities to eliminate cervical cancer by conducting cutting-edge research on early prevention and treatment; implementing sustainable strategies that can be scaled in limited-resource settings; and is leading advocacy for evidence-based strategies and policies. As a medical student in 1997, Dr. Cremer completed a clinical rotation in rural El Salvador where she noted the high incidence of cervical cancer among rural women. This motivated her to develop outreach campaigns, and in 2003, she established Basic Health International. A majority of the organization's fieldwork takes place in El Salvador, while advocacy, research, and education efforts are domestic (US) and global. BHI's offices are headquartered in Pittsburgh, PA with satellite offices in New York, NY and San Salvador, El Salvador.
How we got here (COVID-19 Test Development)
Quick diagnoses are the difference between life and death during the COVID-19 global pandemic we are experiencing. Dr. Cremer and team are taking their field and research experience and applying it to crucial life-saving research during this pivotal moment to help identify and contain the spread of the Coronavirus. BHI's leadership and expertise in identifying and eradicating the HPV virus that causes cervical cancer in underserved communities make our organization uniquely qualified to quickly develop and apply this new test. With nearly 100% of Basic Health International's work taking place in underserved communities, BHI and it's research partners are positioned to quickly connect to and apply testing to our most vulnerable communities at home and beyond.